Published June 3, 2022
Arin Bhattacharjee, PhD, associate professor of pharmacology and toxicology, has been selected to serve on the National Institute of Health’s (NIH) Neurobiology of Pain and Itch (NPI) Study Section for a four-year term.
“NIH study sections are charged with reviewing grant applications and recommending which ones should be funded,” says Bhattacharjee, whose term begins July 1, 2022. “Therefore, this peer review process is critical in directing the future of health-related research in the U.S.”
NPI reviews research grant applications on the neurobiology of pain, analgesia and itch in animals and humans.
“Pain research remains vital because of the ongoing opioid epidemic,” Bhattacharjee says. “The grant applications that go through the NPI could ultimately lead to novel, non-opioid based therapeutics for acute, chronic pain and itch.”
Bhattacharjee’s lab has developed pharmacological tools to target ion channel trafficking, and some of his discoveries have led to filings of patents to treat human disease.
He is excited about the opportunity the selection affords him.
“Being selected definitely bolsters my scientific reputation nationally,” Bhattacharjee says. “It also reinforces the Jacobs School of Medicine and Biomedical Sciences as a strong national research center.”
“Congratulations to Dr. Bhattacharjee on this well-deserved national honor,” says Allison Brashear, MD, MBA, UB’s vice president for health sciences and dean of the Jacobs School. “He will represent the Jacobs School well in this important role.”